{"id":1447362,"name":"Castle Biosciences Inc","transferAgent":{"dtcMemberId":7824,"name":" BROADRIDGE CORPORATE ISSUER SOLUTIONS INC./DRS                        "},"allClaimedTransferAgents":[{"dtcMemberId":7824,"name":" BROADRIDGE CORPORATE ISSUER SOLUTIONS INC./DRS                        ","asOfDate":{"value":"2022-04-21"},"docUrl":"https://www.sec.gov/Archives/edgar/data/1447362/000144736222000061/castle2022proxystatement.htm"},{"dtcMemberId":7824,"name":"Broadridge Corporate Issuer SOlutions, Inc.","asOfDate":{"value":"2020-12-17"},"docUrl":"https://www.nasdaqtrader.com/content/home/help/samplereports/Fundamental_Data_cusip121720.xlsx"}],"tickers":[{"ticker":"CSTL","exchange":"Nasdaq","description":"Common stock","hasOnlinePurchase":null,"cusip":"14843C105"}],"holders":{"filingDate":{"value":"2022-02-28"},"totalHolders":30,"docUrls":["1447362/000144736222000045/cstl-20211231.htm"]}}